These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 21953216)

  • 1. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling.
    Urtasun R; Lopategi A; George J; Leung TM; Lu Y; Wang X; Ge X; Fiel MI; Nieto N
    Hepatology; 2012 Feb; 55(2):594-608. PubMed ID: 21953216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury.
    Arriazu E; Ge X; Leung TM; Magdaleno F; Lopategi A; Lu Y; Kitamura N; Urtasun R; Theise N; Antoine DJ; Nieto N
    Gut; 2017 Jun; 66(6):1123-1137. PubMed ID: 26818617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.
    Mormone E; Lu Y; Ge X; Fiel MI; Nieto N
    Gastroenterology; 2012 Mar; 142(3):612-621.e5. PubMed ID: 22138190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis.
    Son G; Hines IN; Lindquist J; Schrum LW; Rippe RA
    Hepatology; 2009 Nov; 50(5):1512-23. PubMed ID: 19790269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.
    Coombes JD; Choi SS; Swiderska-Syn M; Manka P; Reid DT; Palma E; Briones-Orta MA; Xie G; Younis R; Kitamura N; Della Peruta M; Bitencourt S; Dollé L; Oo YH; Mi Z; Kuo PC; Williams R; Chokshi S; Canbay A; Claridge LC; Eksteen B; Diehl AM; Syn WK
    Biochim Biophys Acta; 2016 Jan; 1862(1):135-44. PubMed ID: 26529285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin delays resolution of liver fibrosis.
    Leung TM; Wang X; Kitamura N; Fiel MI; Nieto N
    Lab Invest; 2013 Oct; 93(10):1082-9. PubMed ID: 23999249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation.
    Seth D; Duly A; Kuo PC; McCaughan GW; Haber PS
    World J Gastroenterol; 2014 Sep; 20(36):13088-104. PubMed ID: 25278703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
    Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
    Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin cleavage of osteopontin controls activation of hepatic stellate cells and is essential for liver fibrogenesis.
    Cui G; Chen J; Wu Z; Huang H; Wang L; Liang Y; Zeng P; Yang J; Uede T; Diao H
    J Cell Physiol; 2019 Jun; 234(6):8988-8997. PubMed ID: 30350863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin induces ductular reaction contributing to liver fibrosis.
    Wang X; Lopategi A; Ge X; Lu Y; Kitamura N; Urtasun R; Leung TM; Fiel MI; Nieto N
    Gut; 2014 Nov; 63(11):1805-18. PubMed ID: 24496779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fam20C-mediated phosphorylation of osteopontin is critical for its secretion but dispensable for its action as a cytokine in the activation of hepatic stellate cells in liver fibrogenesis.
    Tibaldi E; Brocca A; Sticca A; Gola E; Pizzi M; Bordin L; Pagano MA; Mazzorana M; Donà G; Violi P; Marin O; Romano A; Angeli P; Carraro A; Brunati AM
    FASEB J; 2020 Jan; 34(1):1122-1135. PubMed ID: 31914633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice.
    An SY; Jang YJ; Lim HJ; Han J; Lee J; Lee G; Park JY; Park SY; Kim JH; Do BR; Han C; Park HK; Kim OH; Song MJ; Kim SJ; Kim JH
    Gastroenterology; 2017 Apr; 152(5):1174-1186. PubMed ID: 27956229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic stellate cell is activated by microRNA-181b via PTEN/Akt pathway.
    Zheng J; Wu C; Xu Z; Xia P; Dong P; Chen B; Yu F
    Mol Cell Biochem; 2015 Jan; 398(1-2):1-9. PubMed ID: 25148875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maltol Mitigates Thioacetamide-induced Liver Fibrosis through TGF-β1-mediated Activation of PI3K/Akt Signaling Pathway.
    Mi XJ; Hou JG; Jiang S; Liu Z; Tang S; Liu XX; Wang YP; Chen C; Wang Z; Li W
    J Agric Food Chem; 2019 Feb; 67(5):1392-1401. PubMed ID: 30644744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice.
    Ge X; Arriazu E; Magdaleno F; Antoine DJ; Dela Cruz R; Theise N; Nieto N
    Hepatology; 2018 Dec; 68(6):2380-2404. PubMed ID: 29774570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective depletion of hepatic stellate cells-specific LOXL1 alleviates liver fibrosis.
    Yang A; Yan X; Xu H; Fan X; Zhang M; Huang T; Li W; Chen W; Jia J; You H
    FASEB J; 2021 Oct; 35(10):e21918. PubMed ID: 34569648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Igf2bp2 knockdown improves CCl
    Xu Z; He B; Jiang Y; Zhang M; Tian Y; Zhou N; Zhou Y; Chen M; Tang M; Gao J; Peng F
    Int Immunopharmacol; 2022 Sep; 110():108987. PubMed ID: 35820364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPOCK1 overexpression induced by platelet-derived growth factor-BB promotes hepatic stellate cell activation and liver fibrosis through the integrin α5β1/PI3K/Akt signaling pathway.
    Du Z; Lin Z; Wang Z; Liu D; Tian D; Xia L
    Lab Invest; 2020 Aug; 100(8):1042-1056. PubMed ID: 32291390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.
    Syn WK; Choi SS; Liaskou E; Karaca GF; Agboola KM; Oo YH; Mi Z; Pereira TA; Zdanowicz M; Malladi P; Chen Y; Moylan C; Jung Y; Bhattacharya SD; Teaberry V; Omenetti A; Abdelmalek MF; Guy CD; Adams DH; Kuo PC; Michelotti GA; Whitington PF; Diehl AM
    Hepatology; 2011 Jan; 53(1):106-15. PubMed ID: 20967826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tormentic acid inhibits hepatic stellate cells activation via blocking PI3K/Akt/mTOR and NF-κB signalling pathways.
    Lin X; Li Y; Zhang X; Wei Y; Wen S; Lu Z; Huang Q; Wei J
    Cell Biochem Funct; 2021 Jan; 39(1):77-87. PubMed ID: 32564421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.